Wisp Partners With Mount Sinai to Broaden Access to PrEP and HIV Prevention Services Across New York State Wisp, the largest pure-play women’s telehealth provider in the United States, has announced a strategic collaboration with the Mount Sinai Health System…
North Shore University Hospital Device Accelerates Ventilator Weaning in Patients A critically ill patient at Northwell Health’s North Shore University Hospital (NSUH) has become one of the first patients in the United States—and the first on the East Coast—to be…
Neuraptive Therapeutics, Inc. Announces Key Organizational Updates to Advance Its Path Toward Commercialization Neuraptive Therapeutics has announced two key leadership appointments aimed at strengthening both its corporate governance and financial infrastructure as the company advances its development pipeline focused on…
WuXi Biologics Singapore CRDMO Hub Achieves Modular Topping-Out of Drug Product Facility WuXi Biologics (2269.HK), a global leader in Contract Research, Development and Manufacturing Organization (CRDMO) services, has announced the completion of the topping out ceremony for its Drug Product…
CicadaBio to Present CC-18, a Novel GLP-1/ActRII Fusion Protein for Muscle-Sparing Weight Loss, at ADA 2026 CicadaBio has announced new preclinical findings for CC-18, its investigational dual-pathway fusion protein targeting both the GLP-1 receptor and the activin type II receptor…
LivaNova Names Anne Liddy as Chief Legal Officer LivaNova PLC, a global medical technology company specializing in advanced therapeutic solutions, has announced the appointment of Anne Liddy as its new Chief Legal Officer, effective August 31. In this role, she…
OliX Pharmaceuticals Raises KRW 110 Billion in Strategic Investment from L’Oréal’s BOLD and Weiss Asset Management OliX Pharmaceuticals, Inc., a leading biotechnology company specializing in RNA interference (RNAi) therapeutics, has announced the successful raising of approximately KRW 110 billion through…
Rezon Bio Appoints Dr. Ralf Otto as Chief Operating Officer to Strengthen Global CDMO Expansion Strategy Rezon Bio, a science-driven European biologics contract development and manufacturing organization (CDMO), has announced the appointment of Dr. Ralf Otto, PhD, as its new…
Natera Appoints Oncology Leaders Thomas Lynch and Eric Rubin to Board of Directors to Strengthen Precision Medicine Strategy Natera, Inc., a global leader in cell-free DNA testing and precision medicine diagnostics, has announced the appointment of two highly regarded oncology…
Alliance Clinical Network and Atlas Clinical Research Complete Merger to Create Expanded National Clinical Research Platform Alliance Clinical Network and Atlas Clinical Research have announced the successful completion of a strategic merger, creating an expanded clinical research organization with nearly…
Avenzo Reports Updated Phase 1 Data for AVZO-021 Showing Clinical Activity and Favorable Tolerability in Heavily Pretreated HR+/HER2- Breast Cancer Avenzo Therapeutics has announced updated clinical findings from the Phase 1 portion of its ongoing Phase 1/2 clinical study evaluating…
Beren Therapeutics to Present Comprehensive Adrabetadex Data at 2026 NPC Research Conference, Highlighting Early Treatment Benefits and Mechanistic Insights Beren Therapeutics P.B.C., the parent company of Mandos LLC and a biotechnology company focused on cholesterol trafficking biology and cyclodextrin-based therapeutic…